Blood glucose control and metabolic dysfunction-associated steatotic liver disease in people with type 1 diabetes
Giuseppe Della Pepa(University of Bergamo), Lutgarda Bozzetto(Federico II University Hospital), Giovanni Annuzzi(Federico II University Hospital), Salvatore Gianfrancesco(Federico II University Hospital), Roberta Lupoli(University of Naples Federico II), Rebecca Piccolo(Federico II University Hospital), Carmen Rainone(Federico II University Hospital), Rossella De Angelis(Marche Polytechnic University), Maria Masulli(University of Naples Federico II), Ralph V. Boccia(Center for Cancer and Blood Disorders), Angela A. Rivellese(Argonne National Laboratory)
Cited by 14
Related Papers
Avelumab, an anti-PD-L1 antibody, in patients with locally advanced or metastatic breast cancer: a phase 1b JAVELIN Solid Tumor study
|Breast Cancer Research and Treatment|2017|761
Prevention of Type 2 Diabetes by Lifestyle Changes: A Systematic Review and Meta-Analysis
|Nutrients|2019|475
Impact of postprandial glycaemia on health and prevention of disease
|Obesity Reviews|2012|470
Romiplostim or Standard of Care in Patients with Immune Thrombocytopenia
|New England Journal of Medicine|2010|425